Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases
Authors
Keywords
Breast cancer, Receptor tyrosine kinases, Intra-tumor heterogeneity, Tyrosine kinase inhibitor, PDGFR
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-20
DOI
10.1186/s12885-016-2769-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
- (2015) Nicholas McGranahan et al. CANCER CELL
- Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)
- (2015) JING HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update
- (2015) Simona Gurzu World Journal of Clinical Cases
- Inhibition of proliferation and migration of luminal and claudin-low breast cancer cells by PDGFR inhibitors
- (2014) Leanne Stalker et al. Cancer Cell International
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression
- (2014) Evgeny V. Denisov et al. Scientific Reports
- Molecular phenotype of the foci in multifocal invasive breast carcinomas: Intertumoral heterogeneity is related to shorter survival and may influence the choice of therapy
- (2013) Gyula Pekar et al. CANCER
- Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells
- (2013) José Esparza-López et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MET and ERBB2 Are Coexpressed in ERBB2+ Breast Cancer and Contribute to Innate Resistance
- (2013) A. K. Paulson et al. MOLECULAR CANCER RESEARCH
- Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours
- (2012) Brigid C. Browne et al. BREAST CANCER RESEARCH AND TREATMENT
- Dissecting the Heterogeneity of Triple-Negative Breast Cancer
- (2012) Otto Metzger-Filho et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic heterogeneity and cancer drug resistance
- (2012) Nicholas C Turner et al. LANCET ONCOLOGY
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Genome remodelling in a basal-like breast cancer metastasis and xenograft
- (2010) Li Ding et al. NATURE
- Inferring tumor progression from genomic heterogeneity
- (2009) N. Navin et al. GENOME RESEARCH
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- Cross-Talk Between the ErbB/HER Family and the Type I Insulin-Like Growth Factor Receptor Signaling Pathway in Breast Cancer
- (2008) Quanri Jin et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started